TC
AGIO icon

TwinBeech Capital’s Agios Pharmaceuticals AGIO Stock Holding History

TwinBeech Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-141,073
Closed -$4.64M – 689
2024
Q4 		$4.64M Buy
+141,073
New +$6.63M 0.08% 230
2021
Q3 		– Sell
-15,261
Closed -$841K – 553
2021
Q2 		$841K Buy
+15,261
New +$853K 0.1% 231
2020
Q1 		– Sell
-8,320
Closed -$397K – 277
2019
Q4 		$397K Buy
+8,320
New +$314K 0.12% 252

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

TwinBeech Capital's AGIO Position: Q1 2025 in Review

TwinBeech Capital sold out of Agios Pharmaceuticals (AGIO) in Q1 2025, closing a stake of 141,073 shares — an estimated $4.64M sold.

TwinBeech Capital first reported a position in AGIO in Q4 2019 and held it in 3 quarters. The position peaked at $4.64M in Q4 2024. 221 funds tracked by Wall St. Rank hold AGIO as of Q1 2025.

  • TwinBeech Capital reported no remaining Agios Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • TwinBeech Capital sold 141,073 Agios Pharmaceuticals shares in Q1 2025, an estimated $4.64M.
  • TwinBeech Capital first reported a position in Agios Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • TwinBeech Capital's Agios Pharmaceuticals position peaked at $4.64M in Q4 2024.
  • 221 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2025.

Based on TwinBeech Capital's 13F filing for Q1 2025, filed 15 May 2025.